Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Oct 16, 2020 05:32PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Thank you , I believe your understanding is bang on.